Advances in Chemotherapy for Pancreatic Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s13193-014-0371-y.pdf
Reference92 articles.
1. Cameron JL, Riall TS, Coleman J, Belcher KA (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10–15. doi: 10.1097/01.sla.0000217673.04165.ea
2. Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 110:738–744. doi: 10.1002/cncr.22852
3. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825. doi: 10.1056/NEJMoa1011923
4. Chua YJ, Karapetis CS, Gebski V, et al. (2014) Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study. J. Clin. Oncol. 32: (suppl 3; abstr 228)
5. Heestand GM, Murphy JD, Moughan J, et al. (2014) A novel biomarker panel examining response to adjuvant pancreatic cancer therapy in RTOG 9704. J. Clin. Oncol. 32: (suppl 3; abstr 176)
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent trends in anti-cancer activities of terrestrial plants-based polysaccharides: A review;Carbohydrate Polymer Technologies and Applications;2023-12
2. Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy;RSC Advances;2019
3. Association of Modified-FOLFIRINOX-Regimen-Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population;The Oncologist;2018-11-20
4. Pancreatic cancer: a review with future directions;Journal of Radiation Oncology;2016-07-30
5. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model;Nanomedicine: Nanotechnology, Biology and Medicine;2016-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3